HEAD AND NECK SQUAMOUS CELL CANCER
Clinical trials for HEAD AND NECK SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive new cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first-ever study in people for a new drug called EPI-326. It aims to find a safe dose and see how the body handles the drug in patients with advanced lung cancer (with a specific genetic change called EGFR mutation) or advanced head and neck cancer. The main goal is t…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Smart cell therapy aims to target cancer while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of cell therapy called A2B395 for adults with advanced solid tumors that have spread or returned. The therapy uses modified immune cells designed to specifically kill cancer cells while protecting the patient's healthy cells. The main goals are to…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Experimental cancer injection trial seeks to shrink tumors
Disease control Recruiting nowThis early-stage study is testing whether directly injecting an experimental treatment called VLPONC-01 into head and neck tumors is safe and can help shrink them. Researchers are enrolling 41 patients with advanced or surgically removable cancers to receive the injections, somet…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC
-
New hope for advanced cancer patients as experimental drug trial begins
Disease control Recruiting nowThis is the first study in people to test a new drug called XB010 for advanced solid tumors. The main goals are to find a safe dose and see how the body handles the drug, both by itself and when combined with another cancer therapy. It is for adults with certain advanced cancers …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Feb 23, 2026 14:51 UTC